Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma

Cholangiocarcinoma has a poor prognosis and is refractory to conventional chemotherapy and radiation therapy. Improving survival of patients with advanced cholangiocarcinoma urgently requires the development of new effective targeted therapies in combination with chemotherapy. We previously develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Seulki, Lee, Tae Sup, Song, In Ho, Kim, A-Ram, Lee, Yoon-Jin, Kim, Haejung, Hwang, Haein, Jeong, Mun Sik, Kang, Seung Goo, Hong, Hyo Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293259/
https://www.ncbi.nlm.nih.gov/pubmed/28166242
http://dx.doi.org/10.1371/journal.pone.0170078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293259/
https://www.ncbi.nlm.nih.gov/pubmed/28166242
http://dx.doi.org/10.1371/journal.pone.0170078

Ejemplares similares